AVA-2001

N/A

Report date: 2025/06/11 11:20:05

Base Information

Drug NameAVA-2001

Drug Alias NameNKT cell-based vaccine (Avalia Immunotherapies)AVA-1055AVA-2001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulatorsNatural killer cells modulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAvalia Immunotherapies Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAvalia Immunotherapies Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A